[Report on] the Food and Drug Administration’s National Drug Code Directory

Overview:

HHS’ Office of Inspector General found that the Directory is incomplete (with an estimated 9,187 prescription drug products missing) and inaccurate, (with an estimated 34,257 drug products no longer on the market or listed in error). The Office’s report also concluded that FDA’s drug product listing process and lack of oversight contribute to deficiencies in the Directory.